Drug interactions in the intensive care unit

Clinics in Chest Medicine

Volumn 20, Issue 2, 1999, Pages 385-399

  Romac, D R ^a   Albertson, T E ^a  

^a UNIVERSITY OF CALIFORNIA   (United States)

Author keywords

[No Author keywords available]

Indexed keywords

ANTACID AGENT; BARBITURIC ACID DERIVATIVE; CIMETIDINE; CORTISONE; CYTOCHROME P450; DIAZEPAM; DIGOXIN; KETOCONAZOLE; LIDOCAINE; METOCLOPRAMIDE; OPIATE; PARACETAMOL; PHENACETIN O DEETHYLASE; PHENOTHIAZINE DERIVATIVE; PHENYLBUTAZONE; PHENYTOIN; PROPRANOLOL; PROTON PUMP INHIBITOR; QUINIDINE; QUININE; QUINOLONE DERIVATIVE; RANITIDINE; SALICYLIC ACID; SPIRONOLACTONE; SUCRALFATE; SUXAMETHONIUM; THEOPHYLLINE; UNINDEXED DRUG; VALPROIC ACID; WARFARIN;

DRUG ANTAGONISM; DRUG INTERACTION; DRUG POTENTIATION; DRUG TRANSFORMATION; ENZYME INDUCTION; ENZYME INHIBITION; HUMAN; INTENSIVE CARE UNIT; PRIORITY JOURNAL; REVIEW; RISK FACTOR;

EID: 0033019028     PISSN: 02725231     EISSN: None     Source Type: Journal    
DOI: 10.1016/S0272-5231(05)70148-9     Document Type: Article

References (27)

1. E. Albengres H. Le Louët J.P. Tillement Systemic antifungal agents. Drug interactions of clinical significance Drug Saf 18 1998 83
2. T.E. Albertson G.E. Foulke R.S. Tharratt Pharmacokinetics and iatrogenic drug toxicity in the intensive care unit J.B. Hall G.A. Schmidt L.D.H. Wood Principles of Critical Care 1992 McGraw-Hill New York 2061 2079
3. G.D. Anderson A mechanistic approach to antiepileptic drug interactions Ann Pharmacother 32 1998 554
4. J.T. Bigger Jr E.B. Leahey Jr Quinidine and digoxin: An important interaction Drugs 24 1982 229
5. P.L. Bonate K. Reith S. Weir Drug interactions at the renal level. Implications for drug development Clin Pharmacokinet 34 1998 375
6. N.E. Caporaso G.L. Shaw Clinical implications of the competitive inhibition of the debrisoquin-metabolizing isozyme by quinidine Arch Intern Med 151 1991 1985
7. M. Gibaldi Drug interactions: part II Ann Pharmacother 26 1992 829
8. J.R. Guidry T.F. Eastwood S.C. Curry Phenytoin absorption in volunteers receiving selected enteral feedings West J Med 150 1989 659
9. P.D. Hansten Drug Interactions L.Y. Young M.A. Koda-Kimble Applied Therapeutics: The Clinical Use of Drugs 1995 Applied Therapeutics, Inc. Vancouver, WA 381 389
10. P.D. Hansten Understanding Drug Interactions Sci Med 5 1998 16
11. P.D. Hansten J.R. Horn Hansten and Horn's Drug Interactions Analysis and Management 1997 Applied Therapeutics Inc. Vancouver, WA 481 521
12. J.W. Jefferson Drug interactions: Friend or foe? J Clin Psychiatry 59 suppl 4 1998 37
13. L.J. Lee B. Hafkin I.D. Lee Effects of food and sucralfate on a single oral dose of 500 milligrams of levofloxacin in healthy subjects Antimicrob Agents Chemother 41 1997 2196
14. H.J. Mann D.W. Fuhs F.B. Cerra Pharmacokinetics and pharmacodynamics in critically ill patients World J Surg 11 1987 210
15. D.S. McKindley S. Hanes B.A. Boucher Hepatic drug metabolism in critical illness Pharmacotherapy 18 1998 759
16. E.L. Michalets Update: Clinically significant cytochrome P-450 drug interactions Pharmacotherapy 18 1998 84
17. A.A. Moore M.H. Beers Drug interactions in the elderly Hospital Medicine 1992 88 102
18. M.K. Pandit J. Burke A.B. Gustafson Drug-induced disorders of glucose tolerance Ann Intern Med 118 1993 529
19. L. Parnetti D.T. Lowenthal How to recognize and prevent dangerous food-drug interactions The Journal of Critical Illness 13 1998 126 133
20. T.D. Porter M.J. Coon Cytochrome P-450. Multiplicity of isoforms, substrates, and catalytic and regulatory mechanisms J Biol Chem 266 1991 13469
21. C. Rudd J. Wikman P.D. Lumb Drug interactions in critical care P. Lumb C. Bryan-Brown Complications in Critical Care Medicine 1988 Year Book Medical Publishers Chicago, IL 262 279
22. P. Sierra J. Castillo M. Gómez Potential and real drug interactions in critical care patients Rev Esp Anestesiol Reanim 44 1997 383
23. S.P. Spielberg A.S. Nies Principles of therapeutics L.S. Goodman A. Gilman J.G. Hardman Goodman & Gilman's the Pharmacological Basis of Therapeutics 1996 McGraw-Hill Health Professions Division New York 43 62
24. V.A. Strayhorn A.M. Baciewicz T.H. Self Update on rifampin drug interactions, III Arch Intern Med 157 1997 2453
25. D.S. Tatro Drug interactions E.T. Herfindal D.R. Gourley Textbook of Therapeutics: Drug and Disease Management ed 6 1996 Williams & Wilkins Baltimore, MD 33
26. K.E. Thummel G.R. Wilkinson In vitro and in vivo drug interactions involving human CYP3A Annu Rev Pharmacol Toxicol 38 1998 389
27. L.A. Trissel Handbook on injectable drugs ed 9 1996 American Society of Health-System Pharmacists Bethesda, MD xiii xviii